Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Cataract Refract Surg ; 45(4): 485-489, 2019 04.
Article in English | MEDLINE | ID: mdl-30826239

ABSTRACT

PURPOSE: To study the influence of lens thickness and nuclear density on the amount of laser fragmentation energy delivered during femtosecond laser-assisted cataract surgery. SETTING: Ain Shams University and Al-Watany Eye Hospital, Cairo, Egypt. DESIGN: Retrospective case series. METHODS: This study included eyes of patients with primary cataract of different nuclear densities that had femtosecond laser-assisted cataract surgery using the Catalys Precision system. Variables studied included preoperative lens thickness measured by spectral-domain optical coherence tomography, nuclear density using the Lens Opacities Classification System III, pupil size, laser fragmentation energy, total laser energy, and transversal ultrasound time (Ellips FX). Patients were divided according to the preoperative lens thickness as follows: lens thickness more than 4.8 mm (Group 1) and lens thickness 4.8 mm or less (Group 2). RESULTS: The study included 192 eyes of 120 patients. The amount of laser energy for fragmentation was statistically significantly higher in Group 1 than in Group 2 (5.9 J ± 1.5 [SD] versus 4.5 ± 1.8 J) (P < .001). Laser fragmentation energy and total laser time had a strong positive correlation with lens thickness (r = 0.53, P < .001) but not with nuclear density or pupil size. Lens thickness was positively correlated with age (r = 0.42, P < .001) but not with nuclear density. CONCLUSIONS: The preoperative lens thickness, not density, determined the amount of laser energy delivered. The laser might deliver unnecessary energy for softer and thicker nuclei while delivering less energy for thinner but harder nuclei.


Subject(s)
Laser Therapy/methods , Lens, Crystalline/diagnostic imaging , Phacoemulsification/methods , Tomography, Optical Coherence/methods , Visual Acuity , Aged , Female , Follow-Up Studies , Humans , Lens, Crystalline/surgery , Male , Middle Aged , Preoperative Period , Retrospective Studies
2.
Int J Ophthalmol ; 11(3): 445-455, 2018.
Article in English | MEDLINE | ID: mdl-29600179

ABSTRACT

AIM: To evaluate the safety and efficacy of posterior sub-Tenon's carboplatin injection compared to intravitreal melphalan injection in the management of retinoblastoma (RB) with secondary vitreous seeds. The outcome measures were vitreous seeds regression, need for other treatment modalities to achieve ocular salvage and treatment side effects. METHODS: A prospective interventional comparative nonrandomized study included RB eyes developed secondary vitreous seeds during the period of follow up. They subdivided into two groups: study group I where posterior sub-Tenon's carboplatin (20 mg/2 mL) was injected and study group II where intravitreal melphalan (20 µg /0.1 mL) was injected. The injections repeated every 2-4wk. RESULTS: Thirty-three eyes were included in the study. Seventeen eyes (16 patients) in study group I and 16 eyes (16 patients) in study group II. Ten eyes (30.3%) were completely salvaged following local chemotherapies. Ocular salvage was 23.5% following posterior sub-Tenon's carboplatin injection versus 37.5% following intravitreal melphalan raised to 47.1% and 75% with addition of external beam radiotherapy (EBR) with no statistically significant difference between the study groups (P=0.16). A statistically significant correlation was found between ocular salvage rate and type of vitreous seeds either dust, spheres and clouds (r=0.42, P=0.015) and eyes harbor new solid tumor growth (r=0.35, P=0.045). The mean and median follow up periods following local chemotherapy injections were 2.0y in the study group I and 2.37y in the study group II. Few complications were reported: periorbital edema in all eyes and ocular motility disturbances in 13 eyes (76.5%) following posterior sub-Tenon's carboplatin injection. Vitreous hemorrhage developed in 2 eyes (12.5%) and localized retinopathy in 5 eyes (31.25%) following intravitreal melphalan. CONCLUSION: Local chemotherapy for treatment of RB with secondary vitreous seeds is safe and can salvage 30.3% of eyes without EBR. There is a superiority of intravitreal melphalan in ocular salvage however, no statistically significant difference between both groups.

SELECTION OF CITATIONS
SEARCH DETAIL
...